Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disseminated Malignant Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05245136
What this trial is testing

Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.

Who this might be right for
Characteristics DiseaseMetastatic CancerSolid Tumor
University Hospital Augsburg 3,000
Not applicableLooking for participantsNCT07415564
What this trial is testing

Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers

Who this might be right for
Cancer MetastaticSymptoms and SignsQuality of Life
University of Arizona 200
Early research (Phase 1)Looking for participantsNCT05232409
What this trial is testing

Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer

Who this might be right for
Cancer MetastaticMetastatic Solid Tumor
Valley Health System 72
Testing effectiveness (Phase 2)Study completedNCT00012116
What this trial is testing

Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain

Who this might be right for
Metastatic Cancer
Jonsson Comprehensive Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT01108016
What this trial is testing

Expanding Rural Access: Distance Delivery of Support Groups (Main Study)

Who this might be right for
DepressionBreast CancerStress+3 more
Stanford University 100
Testing effectiveness (Phase 2)Ended earlyNCT00112905
What this trial is testing

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Who this might be right for
Adenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more
National Cancer Institute (NCI) 27
Large-scale testing (Phase 3)Active Not RecruitingNCT03525873
What this trial is testing

Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

Who this might be right for
Advanced Malignant NeoplasmMetastatic Malignant NeoplasmRecurrent Malignant Neoplasm
M.D. Anderson Cancer Center 212
Testing effectiveness (Phase 2)Study completedNCT02710253
What this trial is testing

Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid Neoplasm
M.D. Anderson Cancer Center 214
Testing effectiveness (Phase 2)Study completedNCT00243503
What this trial is testing

Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 60
Testing effectiveness (Phase 2)Study completedNCT00817739
What this trial is testing

Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c

Who this might be right for
Prostatic Neoplasms
Takeda 341
Not applicableUnknownNCT02450175
What this trial is testing

Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls

Who this might be right for
Neoplasm
Sinai Hospital of Baltimore 50
Not applicableStudy completedNCT02623257
What this trial is testing

EGFR Mutations on ctDNA in Patients With Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer Metastatic
First People's Hospital of Hangzhou 1,055
Early research (Phase 1)Looking for participantsNCT07658196
What this trial is testing

TLR9 Immunotherapy for Peritoneal Carcinomatosis

Who this might be right for
Malignant AscitesColorectal AdenocarcinomaPeritoneal (Metastatic) Cancer+1 more
Brown University 24
Testing effectiveness (Phase 2)Looking for participantsNCT07008703
What this trial is testing

Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain

Who this might be right for
Cancer Pain
Shenyang Sunshine Pharmaceutical Co., LTD. 132
Testing effectiveness (Phase 2)UnknownNCT00276783
What this trial is testing

Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
Northwestern University 31
Early research (Phase 1)Study completedNCT03941262
What this trial is testing

Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy

Who this might be right for
Refractory CancerMetastatic CancerRecurrent Cancer+4 more
NKGen Biotech, Inc. 27
Testing effectiveness (Phase 2)Study completedNCT01053013
What this trial is testing

Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectablePancreatic Adenocarcinoma MetastaticColorectal Cancer Metastatic
The Rogosin Institute 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT05669482
What this trial is testing

Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

Who this might be right for
KRAS Activating MutationMetastatic CancerPancreas Cancer+2 more
Verastem, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT04659603
What this trial is testing

Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors

Who this might be right for
Breast Cancer MetastaticPancreatic Carcinoma Metastatic
Sanofi 50
Early research (Phase 1)Study completedNCT01295827
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)

Who this might be right for
Cancer, Solid Tumor
Merck Sharp & Dohme LLC 1,260
Next Page